KYSE-30 GFP Reporter Cell Line
The KYSE-30 GFP cell line is transformed from KYSE 30 cell, expressing the GFP gene. The cell constitutively express GFP.
本分类收录的细胞产品与配套技术资料,支持按来源、物种与规格筛选。 共 961 个产品。
The KYSE-30 GFP cell line is transformed from KYSE 30 cell, expressing the GFP gene. The cell constitutively express GFP.
KYSE-30 Luciferase Reporter Cell Line ,esophageal cancer luciferase reporter model for pathway analysis, gene regulation, and oncology drug screening.
KYSE-410 GFP Reporter Cell Line offers a fluorescent esophageal cancer model for transcriptional activity, drug screening, and functional genomic studies.
KYSE-410 Luciferase Reporter Cell Line is designed for esophageal cancer pathway research, enabling drug response analysis using luciferase.
L-02 Luciferase Reporter Cell Line allows sensitive promoter activity detection, gene expression monitoring, and transcription regulation analysis.
L1210 Luciferase Reporter Cell Line, transformed from L1210 cells, expressing firefly luciferase, suitable for gene activation and reporter assays.
The Li-7 Luciferase Reporter Cell Line is designed for the hepatic cancer research, enabling drug screening and pathway activity monitoring.
LL-2 (NFkB) Luciferase Reporter Cell Line delivers sensitive luminescent readouts for NFkB activity, inflammation studies, and therapeutic discovery.
LL-2 (SMAD/TGFbeta) Luciferase Reporter Cell Line supports TGF-尾/SMAD pathway monitoring, drug testing, fibrosis modeling, and cancer mechanism studies.
LL-2 (STAT3) Luciferase Reporter Cell Line enables high-throughput STAT3 pathway research, supporting oncology and signal transduction studies.
Redefine LL/2 Luciferase Reporter Cell Line ,LL/2 luciferase reporter model for oncology research, pathway analysis, and targeted drug discovery.
The LLC EGFP Reporter Cell Line is generated from LLC Cell Line, expressing the EGFP gene. The cells constitutively express EGFP.
The LLC GFP cell line is transformed from LLC cell, expressing the GFP gene. The cell constitutively express GFP.
LLC Luciferase Reporter Cell Line enables sensitive bioluminescence assays for cancer research, drug screening, and gene regulation studies.
LN-229 EGFP Reporter Cell Line provides stable fluorescence for monitoring gene expression, tumor biology, and drug response in glioma studies.
LN-229 Luciferase Reporter Cell Line supports glioblastoma research, enabling bioluminescent monitoring of gene expression and drug response in real time.
LN229 (NFkB) Luciferase Reporter Cell Line provides a reliable luminescent model for NFkB pathway activity, cancer biology, and drug evaluation.
LN229 (SMAD/TGFbeta) Luciferase Reporter Cell Line provides a glioblastoma model to evaluate TGF-beta signaling in tumor growth and progression.
LN229 (STAT3) Luciferase Reporter Cell Line enables glioblastoma research, STAT3 signaling pathway studies, and preclinical drug evaluation assays.
LNCaP (NFkB) Luciferase Reporter Cell Line, transformed from LNCaP cells, expressing firefly luciferase for signaling, drug testing, and pathway analysis.
LNCaP (SMAD/TGFbeta) Luciferase Reporter Cell Line supports prostate cancer research with luminescence-based monitoring of SMAD/TGF-β signaling.
The LNCaP (STAT3) Luciferase Reporter Cell Line enables the real-time monitoring of STAT3 transcriptional activity in prostate cancer research.
Utilize LNCaP Clone FGC EGFP Reporter Cell Line to monitor gene expression, prostate cancer biology, and fluorescence-based assay development in vitro.
LNCAP Luciferase Reporter Cell Line is a prostate cancer model optimized for androgen receptor signaling, tumor biology, and prostate cancer drug testing.
共 961 个产品 | 第 23 / 41 页